ADAM metallopeptidase with thrombospondin type 1 motif, 19
RGD ID:
1308359
Description:
Predicted to enable metalloendopeptidase activity. Predicted to be involved in several processes, including collagen fibril organization; heart valve morphogenesis; and ventricular septum morphogenesis. Predicted to be active in extracellular matrix. Human ortholog(s) of this gene implicated in congenital heart disease. Orthologous to human ADAMTS19 (ADAM metallopeptidase with thrombospondin type 1 motif 19); INTERACTS WITH 6-propyl-2-thiouracil; alpha-Zearalanol; bisphenol A.
A disintegrin and metalloproteinase with thrombospondin motifs 19; a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 19; a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 19; LOC361332
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ...
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ...
[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ...
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ...
[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ...
[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ...
[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ...